Free Trial

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 15.31 +0.22 (+1.42%)
As of 10:38 AM Eastern

CYBG vs. CCFS, CIHL, IL0A, JEO, SLPE, OCI, AGT.LN, AFX, JESC, and BGSC

Should you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), European Opportunities Trust (JEO), Standard Life Private Equity Trust (SLPE), Oakley Capital Investments (OCI), AVI Global Trust (AGT.LN), Alpha FX Group (AFX), JPMorgan European Smaller Companies Trust (JESC), and BMO Global Smaller Companies (BGSC).

VanEck Bionic Engineering UCITS ETF A Acc vs.

Charter Court Financial Services Grp (LON:CCFS) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, community ranking, analyst recommendations, media sentiment, profitability, risk and earnings.

In the previous week, Charter Court Financial Services Grp's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

VanEck Bionic Engineering UCITS ETF A Acc received 104 more outperform votes than Charter Court Financial Services Grp when rated by MarketBeat users. However, 73.88% of users gave Charter Court Financial Services Grp an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote.

CompanyUnderperformOutperform
Charter Court Financial Services GrpOutperform Votes
99
73.88%
Underperform Votes
35
26.12%
VanEck Bionic Engineering UCITS ETF A AccOutperform Votes
203
50.88%
Underperform Votes
196
49.12%

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.18N/A-£7.10-2.16

Company Net Margins Return on Equity Return on Assets
Charter Court Financial Services GrpN/A N/A N/A
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 4 of the 7 factors compared between the two stocks.

Remove Ads
Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYBG vs. The Competition

MetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON Exchange
Market Cap£219.62M£219.62M£11.02B£2.54B
Dividend Yield2.25%2.25%5.47%5.02%
P/E Ratio-2.16N/A23.96153.36
Price / Sales0.1817.7425.42313,448.43
Price / Cash0.130.1317.7028.08
Price / Book0.040.042.734.51
Net IncomeN/AN/A£1.03B£5.73B
7 Day Performance-6.38%-1.28%-1.94%-1.28%
1 Month Performance-11.61%-2.32%-3.30%1.70%
1 Year PerformanceN/A-2.17%10.14%32.87%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYBG
VanEck Bionic Engineering UCITS ETF A Acc
N/AGBX 15.31
+1.4%
N/AN/A£219.62M£1.24B-2.165,762High Trading Volume
CCFS
Charter Court Financial Services Grp
N/AN/AN/AN/A£713.62M£221.10M6.37676Gap Up
CIHL
Caribbean Investment
N/AN/AN/AN/A£35.27M£29.20M3.08N/AGap Up
High Trading Volume
IL0A
Permanent TSB Group
N/AN/AN/AN/A£12.99M£406M5.532,236
JEO
European Opportunities Trust
N/AN/AN/AN/A£886.70M£-62,326,000.00-12.93N/A
SLPE
Standard Life Private Equity Trust
N/AGBX 563
-0.7%
N/A+7.9%£865.59M£251.60M3.63N/A
OCI
Oakley Capital Investments
N/AGBX 476.26
+0.1%
N/A+1.6%£840.17M£99.08M9.54N/A
AGT.LN
AVI Global Trust
N/AN/AN/AN/A£812.93M£51.62M20.82N/AHigh Trading Volume
AFX
Alpha FX Group
N/AN/AN/AN/A£810.18M£89.43M3,200.00214
JESC
JPMorgan European Smaller Companies Trust
N/AN/AN/AN/A£795.72M£114.05M7.60N/A
BGSC
BMO Global Smaller Companies
N/AN/AN/AN/A£769.56M£303.85M2.77N/A
Remove Ads

Related Companies and Tools


This page (LON:CYBG) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners